Effect of heterozygous pathogenic COL4A3 or COL4A4 variants on patients with X‐linked Alport syndrome
Open Access
- 18 March 2019
- journal article
- research article
- Published by Wiley in Molecular Genetics & Genomic Medicine
- Vol. 7 (5) , e647
Abstract
Background: Alport syndrome is an inherited renal disease caused by mutations in COL4A3, COL4A4, or COL4A5 genes. Coexisting mutations in either two of the three genes in Alport patients have been reported recently. However, the effect of heterozygous mutations in COL4A3 or COL4A4 genes in X‐linked Alport syndrome (XLAS) patients is unclear.Methods: Using targeted next‐generation sequencing, six unrelated Chinese children were identified to have a combination of a pathogenic variant in COL4A5 and a heterozygous mutation in COL4A3 or COL4A4. They were three males and three females. Another three XLAS males each with only one pathogenic variant in COL4A5 were included. The clinical data were analyzed and compared between the males in two groups (group 1, males with a pathogenic variant in COL4A5 and a heterozygous pathogenic variant in COL4A3 or COL4A4; group 2, males with only one pathogenic variant in COL4A5).Results: Patients with XLAS who also had heterozygous pathogenic COL4A3 or COL4A4 variants accounted for 1% of Alport syndrome. In this study, three children showed coexisting pathogenic variants in COL4A5 and COL4A3. Two children showed pathogenic variants in COL4A5 and COL4A4. One child had pathogenic variants in the three COL4A3‐5 genes, in which the pathogenic variant in COL4A5 was de novo and the pathogenic variants in COL4A4 and COL4A3 were inherited independently (in trans). The site and type of mutations in COL4A5 were similar between the two groups. It was revealed that males in group 1 presented more severe proteinuria than males in group 2 (p < 0.05).Conclusion: The present study provides further evidence for complicated genotype in Alport syndrome. For the first time, we reported a case with three pathogenic variants in COL4A5, COL4A3, and COL4A4 genes. Moreover, we found that heterozygous pathogenic COL4A3 or COL4A4 variants are likely to make XLAS disease more serious.Keywords
Funding Information
- National Natural Science Foundation of China (81400685)
This publication has 36 references indexed in Scilit:
- The variable course of women with X-linked Alport SyndromeClinical Kidney Journal, 2013
- Clinical practice recommendations for the treatment of Alport syndrome: a statement of the Alport Syndrome Research CollaborativePediatric Nephrology, 2012
- Advances in Alport syndrome diagnosis using next-generation sequencingEuropean Journal of Human Genetics, 2011
- Epidermal basement membrane α5(IV) expression in females with Alport syndrome and severity of renal diseaseKidney International, 2003
- Thin basement membrane nephropathyKidney International, 2003
- Phenotypic and genotypic features of Alport syndrome in Chinese childrenPediatric Nephrology, 2002
- Alport's syndrome.Journal of Medical Genetics, 1997
- Relationship between COL4A5 gene mutation and distribution of type IV collagen in male X-linked Alport syndromeKidney International, 1996
- Identification of mutations in the α3(IV) and α4(IV) collagen genes in autosomal recessive Alport syndromeNature Genetics, 1994
- Identification of Mutations in the COL4A5 Collagen Gene in Alport SyndromeScience, 1990